Coca-cola partners Nigerian Red Cross Society in fight against COVID-19
In a bid to support the fight against the Coronavirus disease, the International Federation of Red Cross and Red Crescent Societies (IFRC) along with its national society Nigerian Red Cross (NRC) has started the distribution of PPES and risk communications efforts to the tune of N228 Million to support its COVID-19 interventions in Nigeria. This is part of The Coca-cola Foundation’s $2.5million grant to the International Federation of Red Cross and Red Crescent Societies (IFRC) to support the COVID-19 pandemic within the West and Central Africa sub-regions.
The grant, which leverages the long-standing partnership between The Coca-cola Company and the International Federation of Red Cross and Red Crescent Societies ( IFRC), seeks to support national efforts in the fight against the Coronavirus disease through the provision of essential medical supplies, personal protective equipment (PPE) and risk communications to impacted communities, healthcare personnel on the frontlines and treatment centres across the country.
Speaking on the donation, Yebeltal Getachew, Managing Director, Coca-cola Nigeria Limited, explained, “The Coca- Cola System ( CocaCola Nigeria, Nigeria Bottling Company and Chi Limited) remains committed to providing support to the communities we serve during these challenging times. By providing healthcare workers with much-needed PPES, we are confident that this will go a long way in ensuring their safety as they remain on the frontlines of the fight against COVID-19.”
Medical supplies being donated comprise N95 respirators, surgical masks, examination gloves, face shields, medical gowns, no- touch thermometers, disposable aprons, heavy-duty rubber gloves, rubber boots, basic masks, disposable gloves, and hand sanitizers.
Expressing his gratitude for the donation, Abubakar Kende, Secretary- General for the Nigerian Red Cross Society explained, “We have identified the facilities in urgent need of these PPES in consultation with NCDC and the Federal Ministry of Health and will subsequently be distributed to these centres.”